![](/img/cover-not-exists.png)
OP21 ABX464 is safe and efficacious in a proof-of-concept study in ulcerative colitis patients
Vermeire, S, Hébuterne, X, Napora, P, Wisniewska-Jarosinska, M, Kiss, G, Bourreille, A, Przemysław, Z, Nitcheu, J, Gineste, P, Steens, J-M, Ehrlich, HVolume:
13
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.020
Date:
January, 2019
File:
PDF, 302 KB
2019